Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

FDA Warns Online Vendors Selling Misbranded Weight-Loss and Diabetes Drugs

The FDA issues warnings to online vendors selling misbranded weight-loss and diabetes drugs, highlighting potential health risks and illegal practices.

Top News

Samsung Galaxy Watch receives FDA authorization for Sleep Apnea Feature

Samsung's sleep apnea feature on the Galaxy Watch has received FDA authorization, allowing users to detect signs of sleep apnea and seek medical care.

Top News

It's Not Too Late to Buy Eli Lilly Stock. Here's Why.

J.P. Morgan thinks sales of weight-loss drugs could exceed $100 billion by 2030. That's good news for Eli Lilly, which is now the largest pharma company by market capitalization and the 9th-biggest S&P 500 stock. Here's why LLY stock looks poised to put on even more weight in the months…

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Galaxy Watch to detect signs of sleep apnea as the FDA gives the all-clear

Samsung's Galaxy Watch will be able to detect signs of sleep apnea in the U.S. as the FDA gives its approval.

Android Central

Why Investors Are Flocking to These 2 Medical Stocks

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

StockNews.com

Research at the heart of a federal case against the abortion pill has been retracted

A research paper that raises questions about the safety of abortion has been retracted. The research is cited in a federal judge's ruling about the abortion pill mifepristone.

WEKU

"Junk" abortion pill studies retracted

“I hope that this will make people more careful about when they cite studies," one lawyer told Salon

Salon

Read news from The Economist, FT, and more,
with one subscription

Rachel Nuwer: MDMA Is On the Cusp of Legalization

In 2024, the FDA will decide whether or not MDMA can be used to treat patients suffering from PTSD.

Reason

Unregulated supplements can be harmful

The myriad potential harms of these products are wide-ranging

Salon

FDA move to ban formaldehyde in hair straighteners called too little, too late

The FDA will soon move to ban formaldehyde in hair-straightening products. It's more than a decade after research raised alarms about health risks and other worrying chemicals remain in the products.

WEKU

FDA busts bogus medicine racket; seizes 21,600 'antibiotic' tablets at Nagpur hospital

“The Maharashtra Food and Drug Administration (FDA) has exposed a bogus medicine racket and seized 21,600 tablets that had been passed off as ‘antibiotic ciprofloxacin’ from a government hospital in Nagpur,” an official said.

The Hindu

Dry January Can Boost Weed Sales: This Week in Cannabis Investing

Reports indicate the annual trend of giving up alcohol in January can help increase recreational cannabis sales.

Kiplinger

Terry Dubrow endorses Ozempic for weight loss, dismisses Tylenol dangers

Terry Dubrow, star of Botched, advocates for the use of Ozempic for weight loss, claiming it is safer than Tylenol and effective in treating obesity.

Top News

3 Lucrative Pharma Stocks for Portfolio Success

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

FTC probe drugmakers’ patent thickets

The Federal Trade Commission has challenged more than 100 patents drugmakers listed in the FDA’s “Orange Book"

Salon

Restricting abortion drug access

The Supreme Court will soon decide the fate of access for mifepristone. The fallout of a ban would be tremendous

WEKU

Up First briefing: Houses passes child tax credit bill; EU agrees on Ukraine aid

The House approved a bipartisan bill that would expand the child tax credit. As tensions between Zelenskyy and his military chief rise, the EU agrees to more than $50 billion in aid for Ukraine.

International Business Times

Biogen Pulls Controversial Alzheimer's Drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Top 4 Pharma Stocks on the Rise for Potential Gains

Growing medical needs, surging demand for precision medicine, favorable regulatory climate, and rapid digital transformation would create promising growth opportunities for pharma companies. Hence, it could be wise to invest in top pharma stocks Johnson & Johnson (JNJ), Spero Therapeutics (SPRO), Ipsen (IPSEY), and Procaps Group (PROC) for solid gains.…

Salon

Philips to stop selling apnea machines

The breathing machine manufacturer has faced relentless criticism over its handling of the 2021 recall of millions

International Business Times UK

Elon Musk's Neuralink Company Implants Brain Chip In A Human For The First Time

Neuralink received FDA permission for its first-in-human clinical trial in May 2023.

International Business Times

Neuralink's Quantum Leap? Elon Musk Claims Brain Implant Breakthrough

Neuralink, Elon Musk's pioneering tech startup, claimed a major milestone with a successful brain implant in a human patient.

Top News

Elon Musk's X prepares for Congressional testimony with new CEO

Discover how Elon Musk's company, X, navigates the regulatory landscape, as its new CEO, Linda Yaccarino, testifies in front of Congress.

Evening Standard

What is Neuralink and how does it work? Elon Musk's firm says first brain-chip patient now plays online chess

A video has been shared on X showing just what the brain chip can do, as well as revealing the identity of the patient for the first time

WEKU

The ketamine economy: New mental health clinics are a 'Wild West' with few rules

Ketamine, approved as an anesthetic in 1970, is emerging as a major alternative mental health treatment. But more than 500 clinics have popped up with little regulation, and treatment varies widely.

1 … 110 111 112 113

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.